mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |